Jazz Pharmaceuticals to buy Redx’s KRAS inhibitor programme
Under the terms of the deal, Jazz will secure all rights, patents, title, and interest in exchange for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Feb 24
Under the terms of the deal, Jazz will secure all rights, patents, title, and interest in exchange for…
08 Feb 24
QSAM is focused on the development of therapeutic radiopharmaceuticals for primary and metastatic bone cancer and its initial…
06 Feb 24
The acquisition is expected to further expand and complement Novartis’ oncology pipeline while helping the firm to develop…
02 Feb 24
The deal involves Fountain Valley Regional Hospital, Lakewood Regional Medical Center, Los Alamitos Medical, Placentia-Linda Hospital, and other…
23 Jan 24
The acquisition is expected to strengthen Sandoz’s ophthalmology portfolio in the US and includes the BLA, product inventory,…
18 Jan 24
Upon completion of the merger, expected to be completed in the first half of this year, Taro will…
16 Jan 24
Acquired the assets of SIBI Medical, operating as the London Spine Institute, adding back, neck and spine specialists…
09 Jan 24
The acquisition will grant Merck access to Harpoon’s two immunotherapies in early-stage development, one for a type of…
09 Jan 24
The deal is expected to grant Novartis access to Cytokinetics' experimental treatment for hypertrophic cardiomyopathy treatment, Aficamten, which…
05 Jan 24
Paragon Healthcare, headquartered in Plano, Texas, offers infusion services to patients via its omnichannel model of ambulatory infusion…